Pharmaceuticals News and Research

RSS

Cells direct membrane traffic by channel width

For a glycerol molecule, a measly angstrom's difference in diameter is a road-closed sign: You can't squeeze through unless you are a sleek, water-molecule-sized sports car, say scientists at the University of Illinois at Urbana-Champaign.

11 Aug 2005

Little convincing evidence that dietary antioxidant supplements such as vitamin E prevent heart disease

Instead there has been a surprise finding, which relates to a synthetic antioxidant, the drug Probucol, which is no longer prescribed in Australia.

11 Aug 2005

Ground-breaking discoveries that provide hope of an alternative treatment option for haemophilia sufferers

Haemophilia is a hereditary blood disease, primarily affecting males, where the blood fails to clot causing potentially life-threatening 'bleeds'. About one in 6000 Australian males is born with haemophilia in severe, moderate or mild form. People with haemophilia rely on intravenous infusion of recombinant Factor VIII clotting protein.

11 Aug 2005

Cancer causing potential of the sex hormones

The cancer causing potential of the sex hormones used in hormone therapy has been known since the 1930s, say researchers and women's health advocates in the Journal of Epidemiology and Community Health.

11 Aug 2005

Scientists enhance the anti-cancer properties of a digitalis, a drug commonly used to treat heart disease

Employing a simple new technique to manipulate the sugars that power many front-line drugs, a team of Wisconsin scientists has enhanced the antic-cancer properties of a digitalis, a drug commonly used to treat heart disease.

9 Aug 2005

Beta-blockers top choice for prevention and rate control for postoperative atrial fibrillation

The American College of Chest Physicians (ACCP) has released the first evidence-based clinical practice guidelines for the prevention and management of postoperative atrial fibrillation (AF) after cardiac surgery.

9 Aug 2005

U.S. drug makers up in arms over info on FDA "Drug Watch" web page

Pharmaceutical companies in the United States are up in arms over plans by U.S. regulators to release preliminary information, about the potential side effects of drugs.

9 Aug 2005

U.S. ready to make bird flu vaccine

Even though officials in the United States say more testing needs to be done, the U.S. could begin mass production of an experimental avian flu vaccine by September.

9 Aug 2005

New guidance highlights pharmacist's role in protecting vulnerable adults

Two new pieces of guidance, Child Protection and Protection of Vulnerable Adults, published by the Royal Pharmaceutical Society of Great Britain this week 6 August 2005 will help pharmacists and registered pharmacy technicians recognise and act on instances where they believe patients may be victims of abuse.

4 Aug 2005

Flu medication VIRA 38 inhibits SARS virus

PRB Pharmaceuticals and Lee's Pharmaceuticals have announced that a recent study by Taiwan researchers from the National Health Research Institutes demonstrates TF2b and TF3, two components of v38 AMF-1, inhibit the 3C-like protease encoded by SARS-CoV. v38 AMF-1, a fraction of the flu medication VIRA 38, is best known for its ability to inhibit bird flu virus (H5N1) infections.

4 Aug 2005

FDA approval for Diovan (Valsartan)

Novartis Pharmaceuticals Corporation announced today that the US Food and Drug Administration (FDA) approved Diovan (valsartan), the most prescribed ARB (angiotensin receptor blocker) in the US and worldwide, for a new indication to reduce cardiovascular death in patients at high risk (with left ventricular failure or left ventricular dysfunction) following a heart attack.

4 Aug 2005

Pfizer adds warning to Celebrex arthritis drug

Pharmaceutical giant Pfizer has adapted the label of its Celebrex arthritis drug and added a prominent warning of possible cardiovascular risks, such as increased risk of heart attacks.

3 Aug 2005

Not enough women take part in heart drug trials

Scientists say because women are under-represented in the clinical trials of heart drugs, doctors are left in the dark as to how treatments may work differently in their bodies.

3 Aug 2005

Successful visceral leishmaniasis vaccine trial in dog

Visceral leishmaniasis, which is the most severe form of that group of diseases, affects 500 000 people in the world each year. It is caused by a protozoan, Leishmania infantum, transmitted by sand fly bites.

2 Aug 2005

Strategic analyses of European In-Vitro cancer diagnostics market - Cancer research yields promising results

Every year, nearly one in four Europeans - a total of almost one million people - dies from cancer, giving Europe the dubious distinction of having amongst the highest cancer-related mortality rates in the world. Even as cancer remains a difficult disease to diagnose, often resulting in either poor diagnosis or misdiagnosis, the number of new cancer cases is set to double by 2020.

2 Aug 2005

Potential new target for cannabis-derived drugs as a treatment of inflammatory bowel disease

Researchers investigating anecdotal evidence that cannabis relieves some of the symptoms of inflammatory bowel disease (IBD) have discovered a potential new target for cannabis-derived drugs for treatment of the disease.

2 Aug 2005

MediciNova starts phase II clinical trial of MN-166 for multiple sclerosis

MediciNova today announced the enrollment of patients in a Phase II clinical study with MN-166 for the treatment of multiple sclerosis (MS), an inflammatory demyelinating disease of the central nervous system. MN-166 is an orally administered drug with a novel mechanism of action that includes the inhibition of phosphodiesterase IV.

2 Aug 2005

Most undergraduate doctors in the UK receive only 5 minutes education on sleep medicine

Teaching staff at Warwick Medical School have long been concerned that trainee doctors do not get enough sleep. Sleep in the classroom that is. Despite sleep patterns being a major contributor to a number of illnesses on average most undergraduate doctors in the UK receive only 5 minutes education on sleep medicine.

28 Jul 2005

Ranbaxy receives tentative approval to manufacture and market Glimepiride tablets

Indian drug manufacturer, Ranbaxy Pharmaceuticals has tentative approval from the U.S. Food and Drug Administration to manufacture and market Glimepiride Tablets, 3 mg and 6 mg.

28 Jul 2005

Pharmaceutical direct-to-consumer to evolve holistically

Restrictions against using brand names have rendered pharmaceutical Direct-to-Consumer Advertising (DTCA) in Europe an informative rather than promotional exercise. DTCA is now broadening its scope, evolving from its narrow publicity orientation to a more comprehensive approach focused on improved patient outcomes and value addition.

27 Jul 2005

Pharmaceuticals News and Research

Cells direct membrane traffic by channel width

Little convincing evidence that dietary antioxidant supplements such as vitamin E prevent heart disease

Ground-breaking discoveries that provide hope of an alternative treatment option for haemophilia sufferers

Cancer causing potential of the sex hormones

Scientists enhance the anti-cancer properties of a digitalis, a drug commonly used to treat heart disease

Beta-blockers top choice for prevention and rate control for postoperative atrial fibrillation

U.S. drug makers up in arms over info on FDA "Drug Watch" web page

U.S. ready to make bird flu vaccine

New guidance highlights pharmacist's role in protecting vulnerable adults

Flu medication VIRA 38 inhibits SARS virus

FDA approval for Diovan (Valsartan)

Pfizer adds warning to Celebrex arthritis drug

Not enough women take part in heart drug trials

Successful visceral leishmaniasis vaccine trial in dog

Strategic analyses of European In-Vitro cancer diagnostics market - Cancer research yields promising results

Potential new target for cannabis-derived drugs as a treatment of inflammatory bowel disease

MediciNova starts phase II clinical trial of MN-166 for multiple sclerosis

Most undergraduate doctors in the UK receive only 5 minutes education on sleep medicine

Ranbaxy receives tentative approval to manufacture and market Glimepiride tablets

Pharmaceutical direct-to-consumer to evolve holistically

Oxygen Measurement eBook - Easily Understand Dissolved Oxygen Measurement eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News